Flucytosine

Flucytosine

SCHEMBL8160959

Nc1nc(=O)[nH]cc1F.Nc1nc(=O)[nH]cc1F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TMP1

The experimentally established mechanism targets of Flucytosine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
CYP19A1 P11511 1/20 0.37
TSHR P16473 1/20 0.37
THPO P40225 1/20 0.37
MTOR P42345 1/20 0.37
HTT P42858 1/20 0.37
HBB P68871 1/20 0.37
PMP22 Q01453 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Flucytosine SCHEMBL24063 1.00
Flucytosine SCHEMBL3868918 0.98 ALDH1A1 (0.35) ALDH1A1LMNAMAPTCYP19A1TSHR
Flucytosine SCHEMBL28748160 0.98
Flucytosine SCHEMBL29100530 0.98 ALDH1A1 (0.35) ALDH1A1LMNAMAPTCYP19A1TSHR
Flucytosine SCHEMBL3871370 0.98 ALDH1A1 (0.35) ALDH1A1LMNAMAPTCYP19A1TSHR
Flucytosine SCHEMBL3869716 0.98 ALDH1A1 (0.35) ALDH1A1LMNAMAPTCYP19A1TSHR
Flucytosine SCHEMBL3870974 0.98 ALDH1A1 (0.35) ALDH1A1LMNAMAPTCYP19A1TSHR
Flucytosine SCHEMBL1050449 0.96 ALDH1A1 (0.34) ALDH1A1LMNAMAPTCYP19A1TSHR
Flucytosine SCHEMBL3867430 0.94 ALDH1A1 (0.33) ALDH1A1LMNAMAPTCYP19A1TSHR
Flucytosine SCHEMBL27696081 0.94 ALDH1A1 (0.33) ALDH1A1LMNAMAPTCYP19A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1960781-A Therapeutic combination for treatment of alzheimers disease WARNER LAMBERT CO (US) 2007-05-09 CN disclosed
EP-1032263-A1 SURFACTANT-BASED ANTIMICROBIAL COMPOSITIONS AND METHODS FOR USING SAME Woodward Laboratories Inc. (US) 2000-09-06 EP disclosed
US-6087400-A MIXTURE CONTAINING BENZALKONIUM CHLORIDE AND WATER WOODWARD LABORATORIES, INC. (US) 2000-07-11 US disclosed
US-6013677-A APPLYING TO THE NAIL A NON-AQUEOUS ANTIMICROBIAL NAIL COATING CONTAINING A FILM FORMING POLYMER, AN ORGANIC SOLVENT, A ANTIMICROBIAL AGENT COMPRISING SOLUBILZED BENZALKONIUM CHLORIDE AND CAPABLE OF LEACHING FROM NAIL COATING WOODWARD LABORATORIES, INC. (US) 2000-01-11 US disclosed
US-5994383-A MIXTURE CONTAINING BENZALKONIUM CHLORIDE AND WATER WOODWARD LABORATORIES, INC. (US) 1999-11-30 US disclosed
WO-1999036033-A1 ANTIMICROBIAL NAIL COATING COMPOSITION WOODWARD LABORATORIES, INC. (US) 1999-07-22 WO disclosed
WO-1999025190-A1 SURFACTANT-BASED ANTIMICROBIAL COMPOSITIONS AND METHODS FOR USING SAME WOODWARD LABORATORIES, INC. (US) 1999-05-27 WO disclosed
WO-1996030011-A1 TOPICAL ANTIMYCOTIC COMPOSITIONS BIOPLEX, L.C. (US) 1996-10-03 WO disclosed